Early research (Phase 1)UnknownNCT06175143
What this trial is testing
Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis.
Who this might be right for
Atopic Dermatitis
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 40